CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion 10b5-1 | +11,280 | $17.76 | $200K | 23,977 |
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −11,280 | $98.54 | $1.1M | 12,697 |
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion · Share Option 10b5-1 | −11,280 | 5,114 | ||
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion 10b5-1 | +4,689 | $10.76 | $50K | 33,751 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion 10b5-1 | +3,932 | $11.10 | $44K | 37,683 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion 10b5-1 | +7,209 | $11.97 | $86K | 44,892 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion 10b5-1 | +4,065 | $17.76 | $72K | 48,957 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −6,030 | $91.87 | $554K | 42,927 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −6,831 | $92.77 | $634K | 36,096 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −9,508 | $94.20 | $896K | 26,588 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −3,705 | $94.86 | $351K | 22,883 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −3,145 | $96.08 | $302K | 19,738 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −1,691 | $97.11 | $164K | 18,047 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −5,350 | $97.74 | $523K | 12,697 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion · Share Option 10b5-1 | −3,932 | 0 | ||
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion · Share Option 10b5-1 | −7,209 | 0 | ||
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion · Share Option 10b5-1 | −4,689 | 2,983 | ||
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion · Share Option 10b5-1 | −4,065 | 16,394 | ||
| 2026-09-03 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −4,600 | $80.30 | $369K | 29,062 |
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion 10b5-1 | +3,932 | 31,629 |
Page 1 of 11 · 206 trades